Clostridium difficile-associated diarrhea and colitis

被引:44
|
作者
Yassin, SF
Young-Adok, TM
Zein, NN
Pardi, DS
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol & Internal Med, Rochester, MN USA
[2] Mayo Clin, Div Colon & Rectal Surg, Rochester, MN USA
关键词
D O I
10.4065/76.7.725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridium difficile is a spore-forming toxigenic bacterium that causes diarrhea and colitis, typically after the use of broad-spectrum antibiotics. The clinical presentation ranges from self-limited diarrhea to fulminant colitis and toxic megacolon, The incidence of this disease is increasing, resulting in major medical and economic consequences. Although most cases respond quickly to medical treatment, C difficile colitis may be serious, especially if diagnosis and treatment are delayed. Recurrent disease represents a particularly challenging problem. Prevention is best accomplished by limiting the use of broad-spectrum antibiotics and following good hygienic techniques and universal precautions to limit the transmission of bacteria. A high index of suspicion results in early diagnosis and treatment and potentially reduces the incidence of complications.
引用
收藏
页码:725 / 730
页数:6
相关论文
共 50 条
  • [21] Review:: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis:: The emergence of a more virulent era
    Hookman, Perry
    Barkin, Jamie S.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (04) : 1071 - 1075
  • [22] Review: Clostridium difficile-Associated Disorders/Diarrhea and Clostridium difficile Colitis: The Emergence of a More Virulent Era
    Perry Hookman
    Jamie S. Barkin
    [J]. Digestive Diseases and Sciences, 2007, 52 : 1071 - 1075
  • [23] Clostridium difficile-associated diarrhea in dialysis patients
    Oh, Sook Eui
    Lee, Seung Min
    Lee, Young-Ki
    Choi, Sun Ryoung
    Choi, Myung-Jin
    Kim, Jwa-Kyung
    Song, Young Rim
    Kim, Soo Jin
    Park, Tae Jin
    Kim, Sung Gyun
    Oh, Jieun
    Suh, Jang Won
    Yoon, Jong -Woo
    Koo, Ja-Ryong
    Kim, Hyung Jik
    Noh, Jung Woo
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (01) : 27 - 31
  • [24] Fluoroquinolone use and Clostridium difficile-associated diarrhea
    McCusker, ME
    Harris, AD
    Perencevich, E
    Roghmann, MC
    [J]. EMERGING INFECTIOUS DISEASES, 2003, 9 (06) : 730 - 733
  • [25] Clostridium difficile-associated diarrhea in a pediatric hospital
    Spivack, JG
    Eppes, SC
    Klein, JD
    [J]. CLINICAL PEDIATRICS, 2003, 42 (04) : 347 - 352
  • [26] Clostridium difficile-Associated Diarrhea in the Oncology Patient
    Neemann, Kari
    Freifeld, Alison
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 25 - +
  • [27] Bezlotoxumab for the treatment of Clostridium difficile-associated diarrhea
    Thakare, R.
    Dasgupta, A.
    Chopra, S.
    [J]. DRUGS OF TODAY, 2017, 53 (07) : 385 - 392
  • [28] Diagnosis of Clostridium difficile-associated diarrhea and odor
    Wilcox, Mark H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 1110 - 1110
  • [29] Management of Severe Clostridium difficile-Associated Diarrhea
    Michael J. Krier
    George Triadafilopoulos
    [J]. Digestive Diseases and Sciences, 2009, 54 : 1199 - 1202
  • [30] Clostridium difficile-associated diarrhea in infants and children
    Vuletic, Biljana
    Ristanovic, Elizabeta
    Markovic, Slavica
    Raskovic, Zorica
    Radlovic, Vladimir
    Igrutinovic, Zoran
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2017, 145 (1-2) : 85 - 88